Search results
Results from the WOW.Com Content Network
In 1911, the anaesthetist Arthur Ernest Guedel first described the use of self-administration of a nitrous oxide and oxygen mix. It was not until 1961 that the first paper was published by Michael Tunstall and others, describing the administration of a pre-mixed 50:50 nitrous oxide and oxygen mix, which led to the commercialisation of the product.
Nitrous oxide (N 2 O), commonly referred to as laughing gas, along with various street names, is an inert gas which can induce euphoria, dissociation, hallucinogenic states of mind, and relaxation when inhaled. [1] Nitrous oxide has no acute biochemical or cellular toxicity and is not metabolized in humans or other mammals.
When water-soluble gases such as anesthetic agent N 2 O (nitrous oxide) are breathed in large quantities they can be dissolved in body fluids rapidly. This leads to a temporary increase [ clarification needed ] in both the concentrations and partial pressures of oxygen and carbon dioxide in the alveoli.
In the developed world, the most frequent type in use is the continuous-flow anaesthetic machine or "Boyle's machine", which is designed to provide an accurate supply of medical gases mixed with an accurate concentration of anaesthetic vapour, and to deliver this continuously to the patient at a safe pressure and flow.
While a few inhalants are prescribed by medical professionals and used for medical purposes, as in the case of inhaled anesthetics and nitrous oxide (an anxiolytic and pain relief agent prescribed by dentists), this article focuses on inhalant use of household and industrial propellants, glues, fuels, and other products in a manner not intended ...
Cryo-S Painless cryoanalgesia device is the next generation of apparatus used by many experts in the field since 1992. The working medium for Cryo-S Painless is carbon dioxide: CO 2 (−78 °C) or nitrous oxide: N 2 O (−89 °C), very efficient and easy to use gases. Cryo-S Painless is controlled by a microprocessor and all the parameters are ...
Monitoring of methemoglobin needed when nitric oxide is in use. Nitric oxide with oxygen (O 2) in combination produces another by-product chemical compound nitrogen dioxide (NO 2). The higher the oxygen concentration and nitric oxide therapy duration and lower ventilator flow rate the higher amount of NO 2 will be produced. NO 2 is toxic and its
These effects occur because of the contraction of alveolar volume associated with the uptake of the nitrous oxide. Previous explanations by Edmond I. Eger and Robert K. Stoelting have appealed to an extra-inspired tidal volume due to a potential negative intrapulmonary pressure associated with the uptake of the nitrous oxide. [2]